Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease

AC. Müller-Nedebock, MCJ. Dekker, MJ. Farrer, N. Hattori, SY. Lim, GD. Mellick, I. Rektorová, M. Salama, AFS. Schuh, AJ. Stoessl, CM. Sue, AH. Tan, RL. Vidal, C. Klein, S. Bardien

. 2023 ; 9 (1) : 110. [pub] 20230713

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23015731

Grantová podpora
Bartlett Fund for Critical Challenges American University in Cairo (AUC)
FOR2488 Deutsche Forschungsgemeinschaft (German Research Foundation)

The biological basis of the neurodegenerative movement disorder, Parkinson's disease (PD), is still unclear despite it being 'discovered' over 200 years ago in Western Medicine. Based on current PD knowledge, there are widely varying theories as to its pathobiology. The aim of this article was to explore some of these different theories by summarizing the viewpoints of laboratory and clinician scientists in the PD field, on the biological basis of the disease. To achieve this aim, we posed this question to thirteen "PD experts" from six continents (for global representation) and collated their personal opinions into this article. The views were varied, ranging from toxin exposure as a PD trigger, to LRRK2 as a potential root cause, to toxic alpha-synuclein being the most important etiological contributor. Notably, there was also growing recognition that the definition of PD as a single disease should be reconsidered, perhaps each with its own unique pathobiology and treatment regimen.

1st Department of Neurology and International Clinical Research Center St Anne's University Hospital and Faculty of Medicine Masaryk University Brno Czech Republic

Applied Neuroscience Research Group CEITEC Masaryk University Brno Czech Republic

Atlantic Senior Fellow for Equity in Brain Health at the Global Brain Health Institute Dublin Ireland

Centro de Biología Integrativa Facultad de Ciencias Universidad Mayor Santiago Chile

Centro FONDAP de Gerociencia Salud Mental y Metabolismo Santiago Chile

Departamento de Farmacologia Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

Department of Internal Medicine Kilimanjaro Christian Medical Centre Moshi Tanzania

Department of Neurology Juntendo University School of Medicine 2 1 1 Hongo Bunkyo ku Tokyo 113 8421 Japan

Department of Neurology Prince of Wales Hospital South Eastern Sydney Local Health District Randwick NSW Australia

Division of Molecular Biology and Human Genetics Department of Biomedical Sciences Faculty of Medicine and Health Sciences Stellenbosch University Cape Town South Africa

Division of Neurology Department of Medicine Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

Faculty of Medicine Mansoura University Dakahleya Egypt

Faculty of Medicine University of New South Wales

Griffith Institute of Drug Discovery Griffith University Brisbane QLD Australia

Institute of Global Health and Human Ecology New Cairo 11835 Egypt

Institute of Neurogenetics University of Lübeck and University Hospital Schleswig Holstein Lübeck Germany

Instituto de Neurociencia Biomédica Facultad de Medicina Universidad de Chile Santiago Chile

Kinghorn Centre for Clinical Genomics Garvan Institute of Medical Research Darlinghurst

Neurodegenerative Disorders Collaborative Laboratory RIKEN Center for Brain Science 2 1 Hirosawa Wako Saitama 351 0106 Japan

Neuroscience Research Australia

Norman Fixel Institute for Neurological Diseases McKnight Brain Institute University of Florida Gainesville FL USA

Pacific Parkinson's Research Centre Department of Medicine Djavad Mowafaghian Centre for Brain Health University of British Columbia Vancouver BC Canada

Research Institute of Disease of Old Age Graduate School of Medicine Juntendo University 2 1 1 Hongo Bunkyo ku Tokyo 113 8421 Japan

Serviço de Neurologia Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

South African Medical Research Council Stellenbosch University Genomics of Brain Disorders Research Unit Stellenbosch University Cape Town South Africa

The Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015731
003      
CZ-PrNML
005      
20231020093638.0
007      
ta
008      
231010s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41531-023-00535-8 $2 doi
035    __
$a (PubMed)37443150
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Müller-Nedebock, Amica C $u Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa $u South African Medical Research Council/Stellenbosch University Genomics of Brain Disorders Research Unit, Stellenbosch University, Cape Town, South Africa
245    10
$a Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease / $c AC. Müller-Nedebock, MCJ. Dekker, MJ. Farrer, N. Hattori, SY. Lim, GD. Mellick, I. Rektorová, M. Salama, AFS. Schuh, AJ. Stoessl, CM. Sue, AH. Tan, RL. Vidal, C. Klein, S. Bardien
520    9_
$a The biological basis of the neurodegenerative movement disorder, Parkinson's disease (PD), is still unclear despite it being 'discovered' over 200 years ago in Western Medicine. Based on current PD knowledge, there are widely varying theories as to its pathobiology. The aim of this article was to explore some of these different theories by summarizing the viewpoints of laboratory and clinician scientists in the PD field, on the biological basis of the disease. To achieve this aim, we posed this question to thirteen "PD experts" from six continents (for global representation) and collated their personal opinions into this article. The views were varied, ranging from toxin exposure as a PD trigger, to LRRK2 as a potential root cause, to toxic alpha-synuclein being the most important etiological contributor. Notably, there was also growing recognition that the definition of PD as a single disease should be reconsidered, perhaps each with its own unique pathobiology and treatment regimen.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Dekker, Marieke C J $u Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Moshi, Tanzania
700    1_
$a Farrer, Matthew J $u Norman Fixel Institute for Neurological Diseases, McKnight Brain Institute, University of Florida, Gainesville, FL, USA
700    1_
$a Hattori, Nobutaka $u Research Institute of Disease of Old Age, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan $u Department of Neurology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan $u Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama, 351-0106, Japan $1 https://orcid.org/0000000220342556
700    1_
$a Lim, Shen-Yang $u Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia $u The Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
700    1_
$a Mellick, George D $u Griffith Institute of Drug Discovery (GRIDD), Griffith University, Brisbane, QLD, Australia $1 https://orcid.org/0000000272114651
700    1_
$a Rektorová, Irena $u First Department of Neurology and International Clinical Research Center, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Applied Neuroscience Research Group, CEITEC, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000254554573
700    1_
$a Salama, Mohamed $u Institute of Global Health and Human Ecology (I-GHHE), The American University in Cairo (AUC), New Cairo, 11835, Egypt $u Faculty of Medicine, Mansoura University, Dakahleya, Egypt $u Atlantic Senior Fellow for Equity in Brain Health at the Global Brain Health Institute (GBHI), Trinity College Dublin (TCD), Dublin, Ireland
700    1_
$a Schuh, Artur F S $u Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil $u Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
700    1_
$a Stoessl, A Jon $u Pacific Parkinson's Research Centre, Department of Medicine (Division of Neurology), Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada
700    1_
$a Sue, Carolyn M $u Neuroscience Research Australia; Faculty of Medicine, University of New South Wales; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst; Department of Neurology, Prince of Wales Hospital, South Eastern Sydney Local Health District, Randwick, NSW, Australia
700    1_
$a Tan, Ai Huey $u Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia $u The Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia $1 https://orcid.org/0000000229793839
700    1_
$a Vidal, Rene L $u Instituto de Neurociencia Biomédica (BNI), Facultad de Medicina, Universidad de Chile, Santiago, Chile $u Centro FONDAP de Gerociencia, Salud Mental y Metabolismo (GERO), Santiago, Chile $u Centro de Biología Integrativa, Facultad de Ciencias, Universidad Mayor, Santiago, Chile $1 https://orcid.org/0000000243057387
700    1_
$a Klein, Christine $u Institute of Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Lübeck, Germany. christine.klein@neuro.uni-luebeck.de $1 https://orcid.org/0000000321023431
700    1_
$a Bardien, Soraya $u Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. sbardien@sun.ac.za $u South African Medical Research Council/Stellenbosch University Genomics of Brain Disorders Research Unit, Stellenbosch University, Cape Town, South Africa. sbardien@sun.ac.za $1 https://orcid.org/0000000235083438
773    0_
$w MED00208625 $t NPJ Parkinson's disease $x 2373-8057 $g Roč. 9, č. 1 (2023), s. 110
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37443150 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093631 $b ABA008
999    __
$a ok $b bmc $g 1997241 $s 1202093
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 9 $c 1 $d 110 $e 20230713 $i 2373-8057 $m NPJ Parkinson's disease $n NPJ Parkinsons Dis $x MED00208625
GRA    __
$a Bartlett Fund for Critical Challenges $p American University in Cairo (AUC)
GRA    __
$a FOR2488 $p Deutsche Forschungsgemeinschaft (German Research Foundation)
LZP    __
$a Pubmed-20231010

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...